NYSE:HQL Abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free HQL Stock Alerts $12.98 +0.18 (+1.41%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$12.85▼$13.0150-Day Range$12.79▼$14.1052-Week Range$11.34▼$14.37Volume73,056 shsAverage Volume111,517 shsMarket Capitalization$340.21 millionP/E RatioN/ADividend Yield10.25%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Abrdn Life Sciences Investors alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Abrdn Life Sciences Investors Stock (NYSE:HQL)Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.Read More HQL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HQL Stock News HeadlinesApril 23, 2024 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Acquires $1,046,246.40 in StockMarch 21, 2024 | finance.yahoo.comabrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team UpdateApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 8, 2024 | msn.comSYRA: Takeaways from Life Science Investor Forum PresentationMarch 1, 2024 | bizjournals.comA 2024 life sciences outlook in Boston – and beyondFebruary 9, 2024 | markets.businessinsider.comabrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in...January 24, 2024 | benzinga.comPeering Into Anavex Life Sciences's Recent Short InterestNovember 23, 2023 | money.usnews.comabrdn Life Sciences InvestorsApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. November 2, 2023 | investing.comAbrdn Life Sciences Investors (HQL)September 26, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 10,096 Shares of Tekla Life Sciences ...September 21, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...August 15, 2023 | seekingalpha.comTekla Life Sciences declares $0.32 dividendJune 20, 2023 | finance.yahoo.comabrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUMMay 17, 2023 | msn.comTekla Life Sciences Investors (HQL) Declares $0.32 DividendMay 15, 2023 | msn.comTekla Life Sciences dividend declines by 3% to $0.32March 21, 2023 | seekingalpha.comHQL Tekla Life Sciences InvestorsNovember 18, 2022 | msn.comTekla Life Sciences: Dividend InsightsNovember 2, 2022 | fool.comTekla Life Sciences Investors (NYSE: HQL)July 14, 2022 | seekingalpha.comHQL: A Biotechnology Equity CEF With No LeverageJune 8, 2022 | news.yahoo.comTekla Looks to Hazy Summer Days for New 'High Summer' Sleepwear CapsuleMay 17, 2022 | seekingalpha.comTekla Life Sciences cuts dividend by 10% to $0.35April 27, 2022 | seekingalpha.comHQL: Buy For The Yield, If You Can Stomach The DepreciationFebruary 11, 2022 | seekingalpha.comTekla Life Sciences Investors: Buy For Steady, Quarterly DividendJanuary 18, 2022 | nasdaq.comTekla Life Sciences Investors Shares Approach 52-Week Low - Market MoverAugust 15, 2021 | forbes.com5 Dividend Funds Yielding Up To 27.2%August 13, 2021 | nasdaq.comTekla Life Sciences Investors Shares Close in on 52-Week High - Market MoverSee More Headlines Receive HQL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/28 Dividend2/21/2024Dividend Payable3/28/2024Today4/23/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Investment offices, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:HQL CUSIPN/A CIK884121 Webwww.teklacap.com Phone(617) 772-8500Fax617-772-8577EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares26,210,000Free Float23,575,000Market Cap$340.21 million OptionableNot Optionable Beta0.71 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Daniel R. Omstead M.S (Age 71)Ph.D., Principal Executive Officer, President and Trustee Mr. Peter BrannerChief Investment OfficerKey CompetitorsTortoise Energy InfrastructureNYSE:TYGSource CapitalNYSE:SORPutnam Premier Income TrustNYSE:PPTBlackRock MuniYield Michigan Quality FundNYSE:MIYBarings Corporate InvestorsNYSE:MCIView All CompetitorsInsiders & InstitutionsRaymond James Financial Services Advisors Inc.Bought 27,012 shares on 4/23/2024Ownership: 0.603%Saba Capital Management, L.P.Bought 81,738 shares on 4/18/2024Total: $1.05 M ($12.80/share)Allspring Global Investments Holdings LLCSold 22,834 shares on 4/18/2024Ownership: 1.646%180 Wealth Advisors LLCBought 9,554 shares on 4/16/2024Ownership: 0.506%Atlantic Union Bankshares CorpSold 3,687 shares on 4/16/2024Ownership: 0.119%View All Insider TransactionsView All Institutional Transactions HQL Stock Analysis - Frequently Asked Questions How have HQL shares performed in 2024? Abrdn Life Sciences Investors' stock was trading at $13.46 at the beginning of 2024. Since then, HQL shares have decreased by 3.6% and is now trading at $12.98. View the best growth stocks for 2024 here. Are investors shorting Abrdn Life Sciences Investors? Abrdn Life Sciences Investors saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 21,300 shares, a decrease of 27.6% from the March 15th total of 29,400 shares. Based on an average daily volume of 113,500 shares, the days-to-cover ratio is currently 0.2 days. View Abrdn Life Sciences Investors' Short Interest. How often does Abrdn Life Sciences Investors pay dividends? What is the dividend yield for Abrdn Life Sciences Investors? Abrdn Life Sciences Investors announced a quarterly dividend on Friday, February 9th. Stockholders of record on Thursday, February 22nd will be paid a dividend of $0.39 per share on Thursday, March 28th. This represents a $1.56 annualized dividend and a yield of 12.02%. The ex-dividend date of this dividend is Wednesday, February 21st. This is a positive change from the stock's previous quarterly dividend of $0.30. Read our dividend analysis for HQL. Is Abrdn Life Sciences Investors a good dividend stock? Abrdn Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.33 per share and currently has a dividend yield of 10.39%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for HQL. What ETFs hold Abrdn Life Sciences Investors' stock? ETFs with the largest weight of Abrdn Life Sciences Investors (NYSE:HQL) stock in their portfolio include Saba Closed-End Funds ETF (CEFS).First Trust Income Opportunities ETF (FCEF). What other stocks do shareholders of Abrdn Life Sciences Investors own? Based on aggregate information from My MarketBeat watchlists, some companies that other Abrdn Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY). Who are Abrdn Life Sciences Investors' major shareholders? Abrdn Life Sciences Investors' stock is owned by many different institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.65%), Raymond James Financial Services Advisors Inc. (0.60%), 180 Wealth Advisors LLC (0.51%), Atlantic Union Bankshares Corp (0.12%) and Future Financial Wealth Managment LLC (0.01%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead, Kathleen Goetz, Saba Capital Management, LP and Todd Reit. View institutional ownership trends. How do I buy shares of Abrdn Life Sciences Investors? Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:HQL) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
